 As
principals, The Channel Group creates, develops, and manages
life sciences companies based on drug candidates and technologies
emanating from medical centers, academic institutions, research
institutes, and commercial R&D organizations.
|

As advisors, The Channel Group is typically engaged by the CEO or Board
of a medical, healthcare, or life sciences company to effect a strategic
transaction. The transactions concluded by The Channel Group and
its Managing Partners have included:
- major financings and recapitalizations
- restructurings and spin-offs
- in-and out-licensing of products and technologies
- reorganization and re-launch of stalled ventures
- acquisitions, mergers, and sales of companies
|